Investors Should Take Note Of ImmunityBio Inc (IBRX)
ImmunityBio Inc (IBRX) concluded trading on Thursday at a closing price of $2.90, with 4.25 million shares of worth about $12.33 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -19.89% during that period and on March 13, 2025 the price saw a gain […]
Now Is A Suitable Moment For A Long-Term Purchase Of ImmunityBio Inc (NASDAQ: IBRX)
Currently, there are 696.83M common shares owned by the public and among those 75.96M shares have been available to trade. Insiders at the company have transacted a total of 0 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 0 of these insider trades were purchases, […]
Better Times Ahead For ImmunityBio Inc (NASDAQ: IBRX)?
ImmunityBio Inc (IBRX) concluded trading on Thursady at a closing price of $5.24, with 5.31 million shares of worth about $27.82 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 208.24% during that period and on Thursady the price saw a gain of about […]
ImmunityBio Inc (IBRX): Insights At A Glance
ImmunityBio Inc (IBRX) concluded trading on Thursday at a closing price of $4.78, with 3.14 million shares of worth about $15.02 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 143.88% during that period and on Thursday the price saw a gain of about […]
Analysts Update Their Price Forecasts For ImmunityBio Inc (IBRX)
ImmunityBio Inc (IBRX) concluded trading on Thursday at a closing price of $3.65, with 4.06 million shares of worth about $14.81 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 88.14% during that period and on Thursday, February 01 price saw a gain of […]
ImmunityBio Inc (NASDAQ: IBRX) Hogging The Spotlight Today
The Vanguard Group, Inc. recently announced the acquisition of new stake in ImmunityBio Inc (NASDAQ:IBRX). The institutional investor has increased its shareholding in the Healthcare company by 43.20% to 14.37 million shares with purchase of 4.34 million shares. This fresh investment now brings its stake to 2.15% valued currently at $72.15 million. In addition, BlackRock […]
Are Analysts Expecting A Better 2020 For ImmunityBio Inc (IBRX)?
ImmunityBio Inc (IBRX) concluded trading on 01/11/24 at a closing price of $3.97, with 3.41 million shares of worth about $13.53 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 47.04% during that period and on Thursday the price saw a loss of about […]
